subscribeSubscribe
BIO campaign gathers pharma partners to lobby Congress against superbugs

BIO campaign gathers pharma partners to lobby Congress against superbugs
Beth Snyder FIERCE PHARMA
31 Aug 2019
Share Share
Key priority is to drive further growth in chronic portfolio: Cipla

Key priority is to drive further growth in chronic portfolio: Cipla
PHARMABIZ
12 Aug 2019
Share Share
Once picked as a $500M winner, bankrupt Achaogen auctions off its antibiotic

Once picked as a $500M winner, bankrupt Achaogen auctions off its antibiotic
John Carroll ENDPTS
07 Jun 2019
Share Share
Achaogen cuts costs again and puts up ‘for sale’ sign

Achaogen cuts costs again and puts up ‘for sale’ sign
Nick Paul Taylor FIERCE BIOTECH
07 Nov 2018
Share Share
Two Genentech vets reunite at I-O to help steer its $33M drive to the clinic

Two Genentech vets reunite at I-O to help steer its $33M drive to the clinic
Amber Tong ENDPTS
19 Sep 2018
Share Share
Tetraphase plots Q4 launch for 1st antibiotic after OK for eravacycline

Tetraphase plots Q4 launch for 1st antibiotic after OK for eravacycline
Amber Tong ENDPTS
28 Aug 2018
Share Share
CMS Grants New Technology Add-on Payment to ZEMDRI™ (plazomicin)

CMS Grants New Technology Add-on Payment to ZEMDRI™ (plazomicin)
YAHOO FINANCE
03 Aug 2018
Share Share
Antibiotics R&D takes another hit as Achaogen slashes research ops

Antibiotics R&D takes another hit as Achaogen slashes research ops
John Carroll ENDPTS
26 Jul 2018
Share Share
Achaogen wins FDA approval for new antibiotic Zemdri

Achaogen wins FDA approval for new antibiotic Zemdri
A. Weintraub FIERCE PHARMA
27 Jun 2018
Share Share
Achaogen slides after ‘yes and no’ adcomm verdict on plazomicin

Achaogen slides after ‘yes and no’ adcomm verdict on plazomicin
Phil Taylor FIERCE BIOTECH
04 May 2018
Share Share